{"entity":{"type":"insider","cik":"0001726096","url":"/insider/0001726096","json_url":"/insider/0001726096.json","name":"Daniell Richard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":52,"n_filings":35,"first":"2018-03-06","last":"2026-05-07","span_basis":"filed_date"},"name_variants":[{"name":"Daniell Richard","source":"filing","n_filings":35,"first_seen":"2018-03-06","last_seen":"2026-05-07"}],"transactions":[{"id":5745927,"accession":"0001193125-26-211833","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-211833","line_url":"/filing/0001193125-26-211833#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (EVP, Europe Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Europe Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Europe Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":35.4,"price_display":"35.40","price_state":"stated","total_value":1062000.0,"total_display":"1,062,000.00","total_whole":"1,062,000","shares_owned_after":55755.0,"shares_owned_after_display":"55,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-07","scope":"insider"},{"id":5929829,"accession":"0001193125-26-098512","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-098512","line_url":"/filing/0001193125-26-098512#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (EVP, Europe Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Europe Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Europe Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17295.0,"shares_display":"17,295","price_per_share":31.6684,"price_display":"31.67","price_state":"stated","total_value":547704.978,"total_display":"547,704.98","total_whole":"547,705","shares_owned_after":85755.0,"shares_owned_after_display":"85,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-09","scope":"insider"},{"id":6111568,"accession":"0001193125-26-096584","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-096584","line_url":"/filing/0001193125-26-096584","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (EVP, Europe Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Europe Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Europe Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91345.0,"shares_display":"91,345","price_per_share":32.662068983524,"price_display":"32.66","price_state":"stated","total_value":2983516.6913,"total_display":"2,983,516.69","total_whole":"2,983,517","shares_owned_after":85755.0,"shares_owned_after_display":"85,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider","n_lines":3},{"id":5929796,"accession":"0001193125-26-093945","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-093945","line_url":"/filing/0001193125-26-093945","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (EVP, Europe Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, Europe Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Europe Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128985.0,"shares_display":"128,985","price_per_share":32.3599,"price_display":"32.36","price_state":"stated","total_value":4173941.7015,"total_display":"4,173,941.70","total_whole":"4,173,942","shares_owned_after":123127.0,"shares_owned_after_display":"123,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-05","scope":"insider","n_lines":2},{"id":4941373,"accession":"0001193125-25-315938","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-315938","line_url":"/filing/0001193125-25-315938#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115468.0,"shares_display":"115,468","price_per_share":28.6757,"price_display":"28.68","price_state":"stated","total_value":3311125.7276,"total_display":"3,311,125.73","total_whole":"3,311,126","shares_owned_after":48384.0,"shares_owned_after_display":"48,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-11","scope":"insider"},{"id":5196885,"accession":"0000950170-25-035489","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-035489","line_url":"/filing/0000950170-25-035489","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70961.0,"shares_display":"70,961","price_per_share":15.905104090979552,"price_display":"15.91","price_state":"stated","total_value":1128642.0914,"total_display":"1,128,642.09","total_whole":"1,128,642","shares_owned_after":48384.0,"shares_owned_after_display":"48,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider","n_lines":2},{"id":4981115,"accession":"0000950170-25-034607","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950170-25-034607","line_url":"/filing/0000950170-25-034607","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48764.0,"shares_display":"48,764","price_per_share":15.9132,"price_display":"15.91","price_state":"stated","total_value":775991.2848,"total_display":"775,991.28","total_whole":"775,991","shares_owned_after":96769.0,"shares_owned_after_display":"96,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider","n_lines":3},{"id":4981094,"accession":"0000950170-25-034607","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-25-034607","line_url":"/filing/0000950170-25-034607","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91608.0,"shares_display":"91,608","price_per_share":15.7346,"price_display":"15.73","price_state":"stated","total_value":1441415.2368,"total_display":"1,441,415.24","total_whole":"1,441,415","shares_owned_after":126784.0,"shares_owned_after_display":"126,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider","n_lines":3},{"id":4460793,"accession":"0000950170-25-033566","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-033566","line_url":"/filing/0000950170-25-033566#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12936.0,"shares_display":"12,936","price_per_share":15.5576,"price_display":"15.56","price_state":"stated","total_value":201253.1136,"total_display":"201,253.11","total_whole":"201,253","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-05","scope":"insider"},{"id":4460790,"accession":"0000950170-25-033566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-033566","line_url":"/filing/0000950170-25-033566#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49314.0,"shares_display":"49,314","price_per_share":16.1855,"price_display":"16.19","price_state":"stated","total_value":798171.747,"total_display":"798,171.75","total_whole":"798,172","shares_owned_after":12936.0,"shares_owned_after_display":"12,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":2117397,"accession":"0000950170-24-096198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-096198","line_url":"/filing/0000950170-24-096198#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98943.0,"shares_display":"98,943","price_per_share":17.2973,"price_display":"17.30","price_state":"stated","total_value":1711446.7539,"total_display":"1,711,446.75","total_whole":"1,711,447","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-13","scope":"insider"},{"id":3253370,"accession":"0000950170-24-027986","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-027986","line_url":"/filing/0000950170-24-027986","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48629.0,"shares_display":"48,629","price_per_share":13.5154,"price_display":"13.52","price_state":"stated","total_value":657240.3866,"total_display":"657,240.39","total_whole":"657,240","shares_owned_after":98943.0,"shares_owned_after_display":"98,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-07","scope":"insider","n_lines":2},{"id":2415456,"accession":"0000950170-24-025982","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-025982","line_url":"/filing/0000950170-24-025982","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95762.0,"shares_display":"95,762","price_per_share":13.3373,"price_display":"13.34","price_state":"stated","total_value":1277206.5226,"total_display":"1,277,206.52","total_whole":"1,277,207","shares_owned_after":69770.0,"shares_owned_after_display":"69,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-05","scope":"insider","n_lines":2},{"id":2513499,"accession":"0000950170-24-023522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-023522","line_url":"/filing/0000950170-24-023522#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20599.0,"shares_display":"20,599","price_per_share":13.116,"price_display":"13.12","price_state":"stated","total_value":270176.484,"total_display":"270,176.48","total_whole":"270,176","shares_owned_after":69770.0,"shares_owned_after_display":"69,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-03-01","scope":"insider"},{"id":8651922,"accession":"0001209191-23-017154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-017154","line_url":"/filing/0001209191-23-017154#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54007.0,"shares_display":"54,007","price_per_share":9.4279,"price_display":"9.43","price_state":"stated","total_value":509172.5953,"total_display":"509,172.60","total_whole":"509,173","shares_owned_after":69770.0,"shares_owned_after_display":"69,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":8651919,"accession":"0001209191-23-017154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-017154","line_url":"/filing/0001209191-23-017154#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18002.0,"shares_display":"18,002","price_per_share":9.9309,"price_display":"9.93","price_state":"stated","total_value":178776.0618,"total_display":"178,776.06","total_whole":"178,776","shares_owned_after":123777.0,"shares_owned_after_display":"123,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":8392013,"accession":"0001209191-23-014435","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-014435","line_url":"/filing/0001209191-23-014435","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44252.0,"shares_display":"44,252","price_per_share":9.8866,"price_display":"9.89","price_state":"stated","total_value":437501.8232,"total_display":"437,501.82","total_whole":"437,502","shares_owned_after":69770.0,"shares_owned_after_display":"69,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-02","scope":"insider","n_lines":2},{"id":6693846,"accession":"0001209191-22-017034","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-017034","line_url":"/filing/0001209191-22-017034#line-6","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22576.0,"shares_display":"22,576","price_per_share":7.3667,"price_display":"7.37","price_state":"stated","total_value":166310.6192,"total_display":"166,310.62","total_whole":"166,311","shares_owned_after":43182.0,"shares_owned_after_display":"43,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":6693842,"accession":"0001209191-22-017034","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-017034","line_url":"/filing/0001209191-22-017034","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36376.0,"shares_display":"36,376","price_per_share":7.4825,"price_display":"7.48","price_state":"stated","total_value":272183.42,"total_display":"272,183.42","total_whole":"272,183","shares_owned_after":43182.0,"shares_owned_after_display":"43,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-08","scope":"insider","n_lines":2},{"id":6890216,"accession":"0001209191-22-014466","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-014466","line_url":"/filing/0001209191-22-014466#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20598.0,"shares_display":"20,598","price_per_share":8.1422,"price_display":"8.14","price_state":"stated","total_value":167713.0356,"total_display":"167,713.04","total_whole":"167,713","shares_owned_after":20280.0,"shares_owned_after_display":"20,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"},{"id":6508290,"accession":"0001209191-22-008409","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008409","line_url":"/filing/0001209191-22-008409#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13135.0,"shares_display":"13,135","price_per_share":9.0605,"price_display":"9.06","price_state":"stated","total_value":119009.6675,"total_display":"119,009.67","total_whole":"119,010","shares_owned_after":20280.0,"shares_owned_after_display":"20,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-10","scope":"insider"},{"id":4330731,"accession":"0001209191-21-018508","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-018508","line_url":"/filing/0001209191-21-018508#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7513.0,"shares_display":"7,513","price_per_share":10.5844,"price_display":"10.58","price_state":"stated","total_value":79520.5972,"total_display":"79,520.60","total_whole":"79,521","shares_owned_after":20280.0,"shares_owned_after_display":"20,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-08","scope":"insider"},{"id":4555087,"accession":"0001209191-21-017755","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017755","line_url":"/filing/0001209191-21-017755#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":993.0,"shares_display":"993","price_per_share":10.8796,"price_display":"10.88","price_state":"stated","total_value":10803.4428,"total_display":"10,803.44","total_whole":"10,803","shares_owned_after":11873.0,"shares_owned_after_display":"11,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-04","scope":"insider"},{"id":4363122,"accession":"0001209191-21-015822","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-015822","line_url":"/filing/0001209191-21-015822#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20598.0,"shares_display":"20,598","price_per_share":10.8509,"price_display":"10.85","price_state":"stated","total_value":223506.8382,"total_display":"223,506.84","total_whole":"223,507","shares_owned_after":10765.0,"shares_owned_after_display":"10,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":4553707,"accession":"0001209191-21-009627","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009627","line_url":"/filing/0001209191-21-009627","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68422.0,"shares_display":"68,422","price_per_share":12.7209,"price_display":"12.72","price_state":"stated","total_value":870389.4198,"total_display":"870,389.42","total_whole":"870,389","shares_owned_after":10765.0,"shares_owned_after_display":"10,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-11","scope":"insider","n_lines":2},{"id":2657375,"accession":"0001209191-20-049921","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-049921","line_url":"/filing/0001209191-20-049921#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":333.0,"shares_display":"333","price_per_share":8.9844,"price_display":"8.98","price_state":"stated","total_value":2991.8052,"total_display":"2,991.81","total_whole":"2,992","shares_owned_after":10765.0,"shares_owned_after_display":"10,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-10","scope":"insider"},{"id":3008540,"accession":"0001209191-20-020161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020161","line_url":"/filing/0001209191-20-020161#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":616.0,"shares_display":"616","price_per_share":7.1714,"price_display":"7.17","price_state":"stated","total_value":4417.5824,"total_display":"4,417.58","total_whole":"4,418","shares_owned_after":10400.0,"shares_owned_after_display":"10,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":3148687,"accession":"0001209191-20-016458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-016458","line_url":"/filing/0001209191-20-016458#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":991.0,"shares_display":"991","price_per_share":11.7657,"price_display":"11.77","price_state":"stated","total_value":11659.8087,"total_display":"11,659.81","total_whole":"11,660","shares_owned_after":9719.0,"shares_owned_after_display":"9,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider"},{"id":2267499,"accession":"0001209191-20-008161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-008161","line_url":"/filing/0001209191-20-008161#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6199.0,"shares_display":"6,199","price_per_share":12.2417,"price_display":"12.24","price_state":"stated","total_value":75886.2983,"total_display":"75,886.30","total_whole":"75,886","shares_owned_after":8612.0,"shares_owned_after_display":"8,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-11","scope":"insider"},{"id":8068668,"accession":"0001209191-19-050261","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-050261","line_url":"/filing/0001209191-19-050261#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1176.0,"shares_display":"1,176","price_per_share":7.8203,"price_display":"7.82","price_state":"stated","total_value":9196.6728,"total_display":"9,196.67","total_whole":"9,197","shares_owned_after":1676.0,"shares_owned_after_display":"1,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-18","filed_date":"2019-09-20","scope":"insider"},{"id":8167038,"accession":"0001209191-19-049108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049108","line_url":"/filing/0001209191-19-049108#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":333.0,"shares_display":"333","price_per_share":7.16,"price_display":"7.16","price_state":"stated","total_value":2384.28,"total_display":"2,384.28","total_whole":"2,384","shares_owned_after":363.0,"shares_owned_after_display":"363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-11","scope":"insider"},{"id":8203379,"accession":"0001209191-19-020161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-020161","line_url":"/filing/0001209191-19-020161#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1297.0,"shares_display":"1,297","price_per_share":16.6446,"price_display":"16.64","price_state":"stated","total_value":21588.0462,"total_display":"21,588.05","total_whole":"21,588","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":8513045,"accession":"0001209191-19-019324","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-019324","line_url":"/filing/0001209191-19-019324#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":715.0,"shares_display":"715","price_per_share":15.6898,"price_display":"15.69","price_state":"stated","total_value":11218.207,"total_display":"11,218.21","total_whole":"11,218","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider"},{"id":8724488,"accession":"0001209191-19-016081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-016081","line_url":"/filing/0001209191-19-016081#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2098.0,"shares_display":"2,098","price_per_share":16.8844,"price_display":"16.88","price_state":"stated","total_value":35423.4712,"total_display":"35,423.47","total_whole":"35,423","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-05","scope":"insider"},{"id":5966037,"accession":"0001209191-18-051770","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-051770","line_url":"/filing/0001209191-18-051770#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2488.0,"shares_display":"2,488","price_per_share":23.691,"price_display":"23.69","price_state":"stated","total_value":58943.208,"total_display":"58,943.21","total_whole":"58,943","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-20","scope":"insider"},{"id":6001048,"accession":"0001209191-18-050469","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-050469","line_url":"/filing/0001209191-18-050469#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":696.0,"shares_display":"696","price_per_share":21.2502,"price_display":"21.25","price_state":"stated","total_value":14790.1392,"total_display":"14,790.14","total_whole":"14,790","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-10","filed_date":"2018-09-11","scope":"insider"},{"id":5996089,"accession":"0001209191-18-020857","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-020857","line_url":"/filing/0001209191-18-020857#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726096","owner_name":"Daniell Richard","owner_display_name":"Daniell Richard","owner_url":"/insider/0001726096","role":"Officer (Exec. VP, European Commercial)","role_mark":"O","role_mark_label":"Officer (Exec. VP, European Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, European Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1297.0,"shares_display":"1,297","price_per_share":17.892,"price_display":"17.89","price_state":"stated","total_value":23205.924,"total_display":"23,205.92","total_whole":"23,206","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-20","scope":"insider"}],"collapsed":true,"next_cursor":"2018-03-19|5996089","ledger_fault":false,"count":{"value":52,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":52,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":52},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (EVP, Europe Commercial)","n_filings":35,"first_seen":"2018-03-06","last_seen":"2026-05-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001726096","retrieved_at":"2026-08-23T11:05:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}